The purpose of this study was to determine whether growth hormone (GH)
secretagogues alter age-related changes in the immune system. Fischer
344 female rats, ranging in age from 3 to 28 months at the start of t
he study were co-administered GH releasing hormone (GHRH; 3 mu g/kg) a
nd GH releasing peptide (GHRP; 100 mu g/kg) to produce episodes of end
ogenous GH secretion once daily for 120 consecutive days. Thymus gland
weights in the older rats administered saline were significantly less
than in younger rats, whereas thymus weights in older rats administer
ed the GH secretagogues were the same as in younger rats. Spleen weigh
ts were not affected by age or treatment. Fluorescence activated cell
sorting (FACS) quantitation of lymphocytes with CD4 and CD8 surface an
tigens revealed that in the thymus gland, CD4(+)CD8(+) lymphocytes dec
reased while CD4(+)CD8(-), CD4(-)CD8(+), and CD4(-)CD8(-) lymphocytes
increased with aging. GHRH and GHRP administration reduced the decreas
e in double-labeled thymocytes that occurs during aging. In the spleen
, CD4(+)CD8(+) and CD--CD8(+) lymphocytes increased while CD4(-)CD8(-)
lymphocytes decreased and CD4(+)CD8(-) lymphocytes remained constant
during aging. The GH secretagogues had no effect on these age-related
changes. However, mitogen-induced proliferation of splenic lymphocytes
which was decreased in the older rats administered saline was signifi
cantly increased in CD4(+) lymphocytes obtained from older rats admini
stered GHRH and GHRP. Proliferation was not affected by administration
of GH secretagogues to the younger rats. The results of this study sh
ow that endogenous GH was effective in completely reversing the effect
of aging on thymic weight loss while partially changing certain aspec
ts of lymphocyte differentiation and proliferation. The differential r
esponses suggest that endogenous GH has selective actions on distinct
elements of the immune system.